March Social Media Round-Up—2025 Annual Review, World’s Most Ethical Companies, and More

Spring has sprung! At Pfizer, we’re celebrating the changing seasons with exciting updates across our social channels.
This March, we received another accolade (Ethisphere recognized Pfizer as one of the World’s Most Ethical Companies for the fifth year in a row), shared new episodes of “Science Will Win” and “What’s In My Lab”, and provided a behind-the-scenes look at our commitment to fighting cancer.
We also published our 2025 Annual Review, with opening remarks from CEO Albert Bourla, while executive leadership announced positive results from our ongoing studies, honored World Obesity Day, and more.
Catch up on other updates:
Executive Leadership
- CEO Albert Bourla shares Pfizer’s 2025 Annual Review
- Chief Scientific Officer Chris Boshoff recognizes the complexities of managing obesity on World Obesity Day
- CEO Albert Bourla highlights Pfizer’s progress in oncology research
- Chief Scientific Officer Chris Boshoff announces positive results from Pfizer's study for people with atopic dermatitis
- CEO Albert Bourla shares an exciting update on Pfizer’s upcoming obesity study
- Chief Scientific Officer Chris Boshoff announces positive topline results in a study for people with homologous recombination repair (HRR) gene-mutated metastatic castration-sensitive prostate cancer (mCSPC)
Pfizer on LinkedIn
- Pfizer is named one of the World’s Most Ethical Companies for the fifth year in a row by Ethisphere
- Pfizer shares a behind-the-scenes look at our latest commitment to fighting cancer
- Pfizer’s latest episode of “Science Will Win” explores the history of breast cancer
- Pfizer announces positive topline results for an investigational vaccine candidate for Lyme disease
Pfizer on Instagram
- Pfizer sits down with Donna and Dr. Max Merz, in this conversation about the realities of living with multiple myeloma
- Pfizer colleague, Laura, shares her personal experience with cancer cachexia
Pfizer on X
Pfizer on TikTok
03.27.2026
03.19.2026
03.12.2026
03.10.2026